SCHEMBL31428795

SCHEMBL31428795

O=C(c1ccc2[nH]ccc2c1)N1CCOCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.60
GPR183 P32249 1/20 0.56
PKM P14618 1/20 0.55
PLK4 O00444 1/20 0.54
JAK2 O60674 1/20 0.54
MAP4K4 O95819 1/20 0.54
ROS1 P08922 1/20 0.54
FGFR1 P11362 1/20 0.54
FLT1 P17948 1/20 0.54
MARK3 P27448 1/20 0.54
FLT4 P35916 1/20 0.54
KDR P35968 1/20 0.54
FLT3 P36888 1/20 0.54
CLK2 P49760 1/20 0.54
CSNK1G2 P78368 1/20 0.54
MAP4K2 Q12851 1/20 0.54
ROCK1 Q13464 1/20 0.54
NTRK3 Q16288 1/20 0.54
MINK1 Q8N4C8 1/20 0.54
AURKB Q96GD4 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22216392 1.00 MAPK14 (0.60) MAPK14GPR183PKMPLK4JAK2
SCHEMBL31428636 0.90 GHSR (0.65) MAPK14PKMPLK4JAK2MAP4K4
SCHEMBL143751 0.90 GHSR (0.65) MAPK14PKMPLK4JAK2MAP4K4
SCHEMBL30226931 0.87 MAPK14 (0.64) MAPK14GPR183SMN1; SMN2ALDH1A1GHSR
SCHEMBL30329646 0.87 MAPK14 (0.64) MAPK14GPR183MAPTGHSRFASN
SCHEMBL8534513 0.87 MAPK14 (0.64) MAPK14GPR183SMN1; SMN2ALDH1A1GHSR
SCHEMBL22216445 0.87 MAPK14 (0.64) MAPK14GPR183MAPTGHSRFASN
Ethoxycarbonyl Group SCHEMBL28090331 0.86 MAPK14 (0.51) MAPK14GPR183POLBALDH1A1MAPT
SCHEMBL2214616 0.85 MAPK14 (0.63) MAPK14GPR183SMN1; SMN2ALDH1A1GHSR
SCHEMBL3457123 0.85 MAPK14 (0.63) MAPK14GPR183SMN1; SMN2ALDH1A1GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS MAPK14 458/4885GPR183 1798/4885PKM 4478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.